These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 19514109)
1. Capture and transmission of HIV-1 by the C-type lectin L-SIGN (DC-SIGNR) is inhibited by carbohydrate-binding agents and polyanions. Auwerx J; François KO; Vanstreels E; Van Laethem K; Daelemans D; Schols D; Balzarini J Antiviral Res; 2009 Jul; 83(1):61-70. PubMed ID: 19514109 [TBL] [Abstract][Full Text] [Related]
2. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1. Hoorelbeke B; Xue J; LiWang PJ; Balzarini J PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304 [TBL] [Abstract][Full Text] [Related]
3. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes. Balzarini J; Van Herrewege Y; Vermeire K; Vanham G; Schols D Mol Pharmacol; 2007 Jan; 71(1):3-11. PubMed ID: 17056872 [TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023 [TBL] [Abstract][Full Text] [Related]
5. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231 [TBL] [Abstract][Full Text] [Related]
6. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells. Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents. Petrova MI; Mathys L; Lebeer S; Noppen S; Van Damme EJ; Tanaka H; Igarashi Y; Vaneechoutte M; Vanderleyden J; Balzarini J J Antimicrob Chemother; 2013 Sep; 68(9):2026-37. PubMed ID: 23640125 [TBL] [Abstract][Full Text] [Related]
8. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. Sabatté J; Ceballos A; Raiden S; Vermeulen M; Nahmod K; Maggini J; Salamone G; Salomón H; Amigorena S; Geffner J J Virol; 2007 Dec; 81(24):13723-34. PubMed ID: 17913809 [TBL] [Abstract][Full Text] [Related]
9. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. van Montfort T; Nabatov AA; Geijtenbeek TB; Pollakis G; Paxton WA J Immunol; 2007 Mar; 178(5):3177-85. PubMed ID: 17312166 [TBL] [Abstract][Full Text] [Related]
10. α(1-6)-Fucosylated Complex Glycan-Binding Lentil Lectin Enhances In Vitro HIV-1 Infection and DC-SIGN-Mediated Viral Capture and Transmission to CD4 Cells. Jan M; Tomer S; Arora SK AIDS Res Hum Retroviruses; 2018 Aug; 34(8):641-644. PubMed ID: 29732900 [No Abstract] [Full Text] [Related]
11. Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators. Pustylnikov S; Dave RS; Khan ZK; Porkolab V; Rashad AA; Hutchinson M; Fieschi F; Chaiken I; Jain P AIDS Res Hum Retroviruses; 2016 Jan; 32(1):93-100. PubMed ID: 26383762 [TBL] [Abstract][Full Text] [Related]
12. Colorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytes. Stax MJ; Mouser EE; van Montfort T; Sanders RW; de Vries HJ; Dekker HL; Herrera C; Speijer D; Pollakis G; Paxton WA PLoS One; 2015; 10(3):e0122020. PubMed ID: 25793526 [TBL] [Abstract][Full Text] [Related]
13. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. Wu L; Martin TD; Vazeux R; Unutmaz D; KewalRamani VN J Virol; 2002 Jun; 76(12):5905-14. PubMed ID: 12021323 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Requena M; Bouhlal H; Nasreddine N; Saidi H; Gody JC; Aubry S; Grésenguet G; Kazatchkine MD; Sekaly RP; Bélec L; Hocini H Immunology; 2008 Apr; 123(4):508-18. PubMed ID: 17999675 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. Sattin S; Daghetti A; Thépaut M; Berzi A; Sánchez-Navarro M; Tabarani G; Rojo J; Fieschi F; Clerici M; Bernardi A ACS Chem Biol; 2010 Mar; 5(3):301-12. PubMed ID: 20085340 [TBL] [Abstract][Full Text] [Related]
16. The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Baribaud F; Doms RW; Pöhlmann S Expert Opin Ther Targets; 2002 Aug; 6(4):423-31. PubMed ID: 12223058 [TBL] [Abstract][Full Text] [Related]
17. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Martínez-Avila O; Bedoya LM; Marradi M; Clavel C; Alcamí J; Penadés S Chembiochem; 2009 Jul; 10(11):1806-9. PubMed ID: 19565596 [No Abstract] [Full Text] [Related]
18. Non-carbohydrate inhibitors of the lectin DC-SIGN. Borrok MJ; Kiessling LL J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657 [TBL] [Abstract][Full Text] [Related]
19. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor. Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146 [TBL] [Abstract][Full Text] [Related]
20. Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods. Ordanini S; Varga N; Porkolab V; Thépaut M; Belvisi L; Bertaglia A; Palmioli A; Berzi A; Trabattoni D; Clerici M; Fieschi F; Bernardi A Chem Commun (Camb); 2015 Mar; 51(18):3816-9. PubMed ID: 25648900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]